Identification of molecular biomarkers of untreated follicular lymphoma treated by GB therapy.
Not Applicable
Recruiting
- Conditions
- Follicular lymphoma
- Registration Number
- JPRN-jRCT1060200019
- Lead Sponsor
- Maeda Yoshinobu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
1) Histologically proven CD20 positive follicular lymphoma (Grade 1, 2, 3A).
2) Age 70-year-old or more.
3) Treated by GB therapy as an initial therapy.
4) Written informed consent
Exclusion Criteria
Patients who refuse to participate in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method